发明名称 REGULATORY T-CELLS FOR USE IN THE TREATMENT OF INFLAMMATORY DISORDERS OF THE HUMAN GASTROINTESTINAL TRACT
摘要 The present invention relates to a composition comprising an isolated CD4+ Treg cell population, wherein the Treg cells have signatures for i) identifying that the T-cells are CD4+ regulatory Tcells, ii) identifying that the Treg cells are tissue type tropic, i.e they can migrate to the diseased tissue, iii) optionally identifying that the Treg cells are tropic with respect to the diseased tissue, i.e. they are homing cells, iv) identifying that the Treg cells are emigrant cells, i.e. they originate from the target tissue, and v) optionally identifying that the Treg cells are retained in the target tissue and optionally one or more X-signatures and/or one or more Y-signatures and one ore more Z-signatures.
申请公布号 US2017035808(A1) 申请公布日期 2017.02.09
申请号 US201515303866 申请日期 2015.04.16
申请人 GENOVIE AB 发明人 Jarvis Reagan Micheal;Thörn Magnus
分类号 A61K35/17;C12N5/0783 主分类号 A61K35/17
代理机构 代理人
主权项
地址 Karlskrona SE